JP2022518527A5 - - Google Patents
Info
- Publication number
- JP2022518527A5 JP2022518527A5 JP2021543164A JP2021543164A JP2022518527A5 JP 2022518527 A5 JP2022518527 A5 JP 2022518527A5 JP 2021543164 A JP2021543164 A JP 2021543164A JP 2021543164 A JP2021543164 A JP 2021543164A JP 2022518527 A5 JP2022518527 A5 JP 2022518527A5
- Authority
- JP
- Japan
- Prior art keywords
- apomorphine
- patient
- dose
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797660P | 2019-01-28 | 2019-01-28 | |
| US62/797,660 | 2019-01-28 | ||
| US201962861077P | 2019-06-13 | 2019-06-13 | |
| US201962861067P | 2019-06-13 | 2019-06-13 | |
| US62/861,077 | 2019-06-13 | ||
| US62/861,067 | 2019-06-13 | ||
| PCT/US2020/015434 WO2020160005A1 (en) | 2019-01-28 | 2020-01-28 | Methods of treating a patient having parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022518527A JP2022518527A (ja) | 2022-03-15 |
| JP2022518527A5 true JP2022518527A5 (cg-RX-API-DMAC7.html) | 2023-02-01 |
Family
ID=71841403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543164A Pending JP2022518527A (ja) | 2019-01-28 | 2020-01-28 | パーキンソン病の患者を治療する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210315882A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3917502A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022518527A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3121531A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021008986A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020160005A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4578461A3 (en) * | 2015-04-21 | 2025-09-03 | Sumitomo Pharma America, Inc. | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa |
| WO2023172649A1 (en) * | 2022-03-11 | 2023-09-14 | Alexza Pharmaceuticals, Inc. | Apomorphine hydrochloride trimethanolate, its polymorphs and its uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2967349B1 (fr) * | 2010-11-15 | 2013-06-14 | Oreal | Composition solide cosmetique de maquillage et/ou de soin |
| EP4578461A3 (en) * | 2015-04-21 | 2025-09-03 | Sumitomo Pharma America, Inc. | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa |
-
2020
- 2020-01-28 EP EP20749249.7A patent/EP3917502A4/en active Pending
- 2020-01-28 MX MX2021008986A patent/MX2021008986A/es unknown
- 2020-01-28 CA CA3121531A patent/CA3121531A1/en active Pending
- 2020-01-28 WO PCT/US2020/015434 patent/WO2020160005A1/en not_active Ceased
- 2020-01-28 JP JP2021543164A patent/JP2022518527A/ja active Pending
-
2021
- 2021-06-10 US US17/344,314 patent/US20210315882A1/en not_active Abandoned